Kangstem Biotech Co., Ltd. (KOSDAQ:217730)
South Korea · Delayed Price · Currency is KRW 3,035.00
-70.00 (-2.25%)
At close: May 20, 2026
Kangstem Biotech Market Cap
Kangstem Biotech has a market cap or net worth of 285.45 billion as of May 21, 2026. Its market cap has increased by 109.14% in one year.
Market Cap
285.45B
Enterprise Value
256.70B
Revenue
3.57B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,035.00
Market Cap Chart
Since December 21, 2015, Kangstem Biotech's market cap has increased from 129.33B to 285.45B, an increase of 120.72%. That is a compound annual growth rate of 7.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 285.45B | 30.82% |
| Dec 30, 2025 | 218.21B | 92.71% |
| Dec 30, 2024 | 113.23B | -15.48% |
| Dec 28, 2023 | 133.97B | 21.98% |
| Dec 29, 2022 | 109.83B | -11.47% |
| Dec 30, 2021 | 124.06B | -36.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventage Lab | 683.78B |
| Curocell | 593.40B |
| IMBiologics | 568.48B |
| curacle co.,ltd. | 274.82B |
| TiumBio | 269.70B |
| ViGenCell | 211.14B |
| Ensol Biosciences | 177.45B |
| CORESTEMCHEMON | 165.91B |